Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Receptors, Corticotropin
Leukemia Inhibitory Factor Receptor alpha Subunit
trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride
Episiotomy
High-dose cladribine therapy for chronic myelogenous leukemia in the accelerated or blast phase.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
High-dose cladribine therapy for chronic myelogenous leukemia in the accelerated or blast phase.
High-dose cladribine therapy for chronic myelogenous leukemia in the accelerated or blast phase. J Clin Oncol. 1998 Apr; 16(4):1498-504.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Agents
Bone Marrow
Cladribine
Dose-Response Relationship, Drug
Female
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Male
Middle Aged
Survival Analysis
Treatment Outcome
authors with profiles
Richard A. Larson